Intelligent Bio Solutions News

Intelligent Bio Solutions Q3 EPS $(1.43) Beats $(2.52) Estimate

Intelligent Bio Solutions (NASDAQ:INBS) reported quarterly losses of $(1.43) per share which beat the analyst consensus estimate of $(2.52) by 43.25 percent. This is a 97.92 percent increase over loss

BenzingaMay 8 08:37 ET

Intelligent Bio Solutions | 10-Q: Quarterly report

Futu NewsMay 8 08:33 ET · Announcements

Earnings Flash (INBS) INTELLIGENT BIO SOLUTIONS Reports Q3 Revenue $823,800

08:31 AM EDT, 05/08/2024 (MT Newswires) -- Earnings Flash (INBS) INTELLIGENT BIO SOLUTIONS Reports Q3 Revenue $823,800

MT NewswiresMay 8 08:31 ET

Express News | Intelligent Bio Solutions Q3 Basic EPS USD -1.43

ReutersMay 8 08:30 ET

Express News | Intelligent Bio Solutions Q3 Net Income USD -2.98 Million

ReutersMay 8 08:30 ET

Express News | Intelligent Bio Solutions Inc. Reports Fiscal 2024 Third Quarter and Nine-Month Financial Results and Operational Highlights

ReutersMay 8 08:30 ET

Press Release: Intelligent Bio Solutions Inc. Reports Fiscal 2024 Third Quarter and Nine-Month Financial Results and Operational Highlights

Intelligent Bio Solutions Inc. Reports Fiscal 2024 Third Quarter and Nine-Month Financial Results and Operational Highlights Year-over-year revenue increased 80% for the fiscal third quarter and 193%

Dow JonesMay 8 08:30 ET

Intelligent Bio Solutions 3Q Loss $2.99M >INBS

Intelligent Bio Solutions 3Q Loss $2.99M >INBS

Dow JonesMay 8 08:30 ET

Intelligent Bio Solutions 3Q Rev $823,800 >INBS

Intelligent Bio Solutions 3Q Rev $823,800 >INBS

Dow JonesMay 8 08:30 ET

Intelligent Bio Solutions 3Q Loss/Shr $1.43 >INBS

Intelligent Bio Solutions 3Q Loss/Shr $1.43 >INBS

Dow JonesMay 8 08:30 ET

Intelligent Bio Solutions Inc. Reports Fiscal 2024 Third Quarter And Nine-Month Financial Results and Operational Highlights

Year-over-year revenue increased 80% for the fiscal third quarter and 193% for the nine months ended March 31, 2024Cash and cash equivalents as of March 31, 2024, was $9.40 millionCommenced FDA 510(k)

Intelligent Bio SolutionsMay 8 00:00 ET

12 Health Care Stocks Moving In Friday's Pre-Market Session

GainersChromocell Therapeutics (AMEX:CHRO) stock increased by 21.6% to $1.49 during Friday's pre-market session. The company's market cap stands at $8.7 million. Kineta (NASDAQ:KA) stock moved upwards

BenzingaApr 19 08:08 ET

Intelligent Bio Solutions Reports Preliminary Unaudited Fiscal Q3 Results

Seeking AlphaApr 18 14:58 ET

Express News | Intelligent Bio Solutions Sees Prelim. Q3 2024 Revenue $0.82M Vs $1.190M Est

Moomoo 24/7Apr 18 08:38 ET

Intelligent Bio Solutions Sees 3Q Rev of Around $820,000>INBS

Intelligent Bio Solutions Sees 3Q Rev of Around $820,000>INBS

Dow JonesApr 18 08:34 ET

Express News | Intelligent Bio - Cartridge and Reader Sales Are Expected to Increase 25% and 63%, Respectively, From July 1, 2023, Through to March 31, 2024

Moomoo 24/7Apr 18 08:31 ET

Express News | Intelligent Bio Solutions Inc - Sees Qtrly Year-Over-Year Increase of 17% in Cartridge Sales

Moomoo 24/7Apr 18 08:30 ET

Express News | Intelligent Bio Solutions Inc - Expects Approximate Unaudited Revenue of $0.82 Mln for Three Months Ended March 31, 2024

Moomoo 24/7Apr 18 08:30 ET

Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Third Quarter and Nine-Month Revenue Results

Year-over-year unaudited revenue increased 80% for the fiscal third quarter and 193% for the nine months ended March 31, 2024, with highest quarterly cartridge sales since 2022 Intelligent Fingerprint

Intelligent Bio SolutionsApr 18 00:00 ET

Express News | Intelligent Bio Solutions Subsidiary Fingerprinting Granted New European Patent With Unitary Effect For DSR-Plus Cartridge Reader

Moomoo 24/7Apr 11 08:44 ET